THE ANTITUMOR-ACTIVITY AND IMMUNOSUPPRESSIVE EFFECTS OF 5-FLUOROURACIL SUPPOSITORIES IN RECTAL-CANCER PATIENTS

被引:5
|
作者
ADACHI, W
SUGENOYA, A
HORIGOME, N
TAKAHASHI, C
IIDA, F
NAKAYAMA, J
机构
[1] Department of Surgery, Shinshu University School of Medicine, Nagano, 390
[2] Central Clinical Laboratories, Shinshu University Hospital, Matsumoto
来源
关键词
5FU SUPPOSITORY; RECTAL CANCER; TISSUE CONCENTRATION OF 5FU; LYMPHOCYTE SUBSET OF REGIONAL LYMPH NODES;
D O I
10.1007/BF00308826
中图分类号
R61 [外科手术学];
学科分类号
摘要
The antitumor activity and immunological effects of the local administration of 5FU were investigated by determining the tissue concentration of 5FU, histological appearance of the primary tumor, and lymphocyte subsets of the regional lymph nodes in 23 rectal cancer patients. Twelve patients were treated with 5FU suppositories preoperatively, being the 5FU group, while 11 patients were given no preoperative treatment, being the control group. The 5FU concentrations in the primary tumors were higher than those in the regional lymph nodes and appeared to remain high for an extended period. No histological changes peculiar to the 5FU group were observed in the primary tumors. An analysis of the lymphocyte subsets in the pararectal nodes revealed that Leu2a+15- cells, or cytotoxic T lymphocytes, were significantly decreased in numbers in the 5FU group compared to the control group. These results suggest that the local use of 5FU may not only exert an antitumor effect against rectal cancer, but can also cause the suppression of antitumor immunity in the regional lymph nodes.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [1] PREOPERATIVE COMBINED TREATMENT WITH RADIATION, INTRALUMINAL HYPERTHERMIA, AND 5-FLUOROURACIL SUPPOSITORIES FOR PATIENTS WITH RECTAL-CANCER
    TAKAHASHI, T
    HORIE, H
    KOJIMA, O
    ITOH, M
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1993, 23 (12): : 1043 - 1048
  • [2] ENHANCEMENT OF ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL BY RIBOTHYMIDINE
    TEZUKA, M
    CHIBA, Y
    OKADA, S
    TAMEMASA, O
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (08): : 683 - 687
  • [3] ENHANCEMENT OF THE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL BY URIDINE RESCUE
    KLUBES, P
    LEYLANDJONES, B
    PHARMACOLOGY & THERAPEUTICS, 1989, 41 (1-2) : 289 - 302
  • [4] METABOLISM AND ANTITUMOR-ACTIVITY OF 1-PHTHALIDYL 5-FLUOROURACIL
    TONDA, K
    KASAI, H
    SHIRATORI, O
    HIRATA, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1986, 9 (06): : S48 - S48
  • [5] PHARMACOKINETIC MODULATION OF PLASMA 5-FLUOROURACIL CONCENTRATIONS TO POTENTIATE THE ANTITUMOR-ACTIVITY OF CONTINUOUS VENOUS INFUSION OF 5-FLUOROURACIL
    FUJII, S
    FUKUSHIMA, M
    SHIMAMOTO, Y
    SHIRASAKA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (06): : 509 - 512
  • [6] ANTITUMOR-ACTIVITY OF BOF-A2, A NEW 5-FLUOROURACIL DERIVATIVE
    FUJII, S
    FUKUSHIMA, M
    SHIMAMOTO, Y
    OHSHIMO, H
    IMAOKA, T
    SHIRASAKA, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (02): : 173 - 181
  • [7] POTENTIATION OF ANTITUMOR-ACTIVITY OF 1-PHTHALIDYL 5-FLUOROURACIL BY ACETAZOLAMIDE
    KASAI, H
    TONDA, K
    HIRATA, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 16 (01) : 55 - 57
  • [8] SYNTHESIS AND ANTITUMOR-ACTIVITY OF POLYMERIC DRUGS CONTAINING 5-FLUOROURACIL IN THE MAIN CHAIN
    LIAO, J
    ZHUO, RX
    POLYMER JOURNAL, 1991, 23 (10) : 1269 - 1272
  • [9] COMPARATIVE ANTITUMOR-ACTIVITY OF 5-FLUOROURACIL AND ITS PRODRUGS IN COMBINATION WITH HYPERTHERMIA INVITRO
    SHIIKI, S
    FUCHIMOTO, S
    IWAGAKI, H
    AKAZAI, Y
    MATSUBARA, N
    WATANABE, T
    ORITA, K
    ACTA MEDICA OKAYAMA, 1991, 45 (05) : 339 - 345
  • [10] INTRA-ARTERIAL INFUSION CHEMOTHERAPY (5-FLUOROURACIL) IN PATIENTS WITH INEXTIRPABLE OR LOCALLY RECURRENT RECTAL-CANCER
    HAFSTROM, L
    JONSSON, PE
    LANDBERG, T
    OWMAN, T
    SUNDKVIST, K
    AMERICAN JOURNAL OF SURGERY, 1979, 137 (06): : 757 - 762